# US 2023/0067942 A1 · IMPROVEMENT IN PULMONARY ARTERIAL COMPLIANCE WITH INHALED NITRIC OXIDE (iNO) TREATMENT

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0067942 A1
- Document ID: US20230067942A1
- Status: Published application
- Kind: A1
- Application number: 17/796,451
- Filed: 2021-01-27
- Published: 2023-03-02
- Earliest claimed: 2020-01-31
- Assignees: Bellerophon Therapeutics
- Applicants: Bellerophon Therapeutics
- Inventors: Parag SHAH; Peter FERNANDES
- Web page: https://patentgrep.com/patent/US20230067942A1

## CPC

- A61K 9/007: {Pulmonary tract; Aromatherapy}
- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 11/00: Drugs for disorders of the respiratory system
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Described are methods for reducing pulmonary resistance, reducing pulmonary pressure, and increasing pulmonary arterial compliance by providing a inhaled nitric oxide.

## Claims

### Claim 1

A method of reducing pulmonary pressure comprising delivering to a patient one or more doses of inhaled nitric oxide over a time period.

### Claim 2

A method of reducing pulmonary resistance comprising delivering to a patient one or more doses of inhaled nitric oxide over a time period.

### Claim 3

A method of increasing arterial compliance comprising delivering to a patient one or more doses of inhaled nitric oxide over a time period.

### Claim 4

The method of any of the preceding claims wherein the time period is 5, 10, 15, 20, 25, 30, 60, or 90 minutes.

### Claim 5

The method of any of the preceding claims wherein the dose of inhaled nitric oxide is a dose-escalating pulsed dose.

### Claim 6

The method of any of the preceding claims wherein the dose of inhaled nitric oxide is one or more of a iNO30, iNO45, and iNO75 dose.
